As Nxera Pharma proceeds into the “next era” implied by its name—following a rebrand from Sosei Group last year—the Japanese drugmaker is adding a new executive to help guide its growth plans. Kiyoshi ...
As President Donald Trump’s tariff policies loom, global pharmaceutical giant AstraZeneca will invest $50 billion to boost its American manufacturing and R&D infrastructure. Chief among the company’s ...
After several weeks and thousands of votes, TV drug ads from Apellis Pharmaceuticals and AstraZeneca found themselves in the final round of the annual #FierceMadness bracket competition. The trophy ...
10d
ASCO 2026: A quiet conference for European pharma, but AstraZeneca and Roche both have work to do
This year's American Society of Clinical Oncology (ASCO) conference has been a subdued affair for European pharmaceutical ...
CAMBRIDGE, England--(BUSINESS WIRE)--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the ...
The FDA said in a statement: “Since approval, the FDA has received postmarketing safety data on thromboembolic events, including serious and fatal outcomes, in patients treated with Andexxa. Based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results